Summary
Overview
Work History
Education
Certification
Timeline
Generic

JASON ZHUANG

Cliffside Park,USA

Summary

Sell-side Equity Research Associate with ~4 years of experience covering US large cap biopharma.

Overview

4
4
years of professional experience
1
1
Certification

Work History

Equity Research Associate

Leerink Partners LLC
12.2023 - Current
  • Equity Research Associate covering US Diversified Biopharma, incl. ABBV, BMY, PFE, JNJ, LLY, REGN, AMGN, SAN FP, VRTX, HALO, XOMA, CNTA, ANAB, ROIV, GPCR, PCVX.
  • Senior Analyst: David Risinger
  • Conducted extensive research on Washington policies, including drug pricing, tariffs, MFN, and FDA.
  • Wrote research notes and therapeutics deep dives; Built and maintained financial models.
  • Interacted with investors on a daily basis.

Equity Research Associate

BNP Paribas Securities Corp
08.2022 - 12.2023
  • Sell-side equity research associate focusing on US healthcare, Specialty Pharma / Large- Cap Pharma / Biotechnology.
  • Senior analyst: Navann Ty.
  • Covering: ABBV, MRK, OGN, HOLX, NTRA, SKIN, RVNC, EOLS, COO, KVUE, ELAN, ZTS, PAHC, IDXX
  • Functioned as the only associate on the team
  • Prepared 3-statement financial models with DCF/multiple valuation for initiation
  • Wrote earnings reviews and flash notes, updated model and projections
  • Communicated with company management and KOLs, wrote takeaway notes
  • Organized fireside chats with well-reputed scientists on female aging and GeroScience

Equity Research Analyst

Haitong Securities USA
11.2021 - 07.2022
  • Sell-side equity research analyst with a focus on China biotech, and US biopharma.
  • Senior Analyst: Linda Shu
  • Conducted research on the correlation between US interest rate and US biotech stock prices (NBI, XBI)
  • Facilitated the preparation of AI drug development industry report (RXRX, SDGR, EXAI, Insilico)
  • Communicated with China and US investors, company management and KOLs
  • Tracked and managed global COVID-19 data, sent early alerts about Omicron in South Africa to Chinese investors

Education

Master of Public Health - Epidemiology, Biostatistics, Virology

Cornell University
Ithaca, New York
05.2021

Bachelor of Science - Pharmaceutical Science, Biochemistry, Pharmacology

Fudan University
07.2019

Certification

  • Series 63, 86&87, FINRA
  • SIE, FINRA
  • Financial Modeling, CFA Institute

Timeline

Equity Research Associate

Leerink Partners LLC
12.2023 - Current

Equity Research Associate

BNP Paribas Securities Corp
08.2022 - 12.2023

Equity Research Analyst

Haitong Securities USA
11.2021 - 07.2022

Bachelor of Science - Pharmaceutical Science, Biochemistry, Pharmacology

Fudan University

Master of Public Health - Epidemiology, Biostatistics, Virology

Cornell University

Similar Profiles

CREATE PROFILE
JASON ZHUANG